"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Descriptor ID |
D007333
|
MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1996 | 4 | 0 | 4 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 1 | 2 | 3 |
2001 | 2 | 3 | 5 |
2002 | 2 | 3 | 5 |
2003 | 3 | 2 | 5 |
2004 | 7 | 10 | 17 |
2005 | 7 | 8 | 15 |
2006 | 10 | 10 | 20 |
2007 | 6 | 8 | 14 |
2008 | 5 | 10 | 15 |
2009 | 8 | 9 | 17 |
2010 | 12 | 11 | 23 |
2011 | 20 | 11 | 31 |
2012 | 20 | 22 | 42 |
2013 | 13 | 12 | 25 |
2014 | 12 | 14 | 26 |
2015 | 13 | 16 | 29 |
2016 | 13 | 21 | 34 |
2017 | 11 | 19 | 30 |
2018 | 10 | 14 | 24 |
2019 | 6 | 13 | 19 |
2020 | 19 | 11 | 30 |
2021 | 13 | 9 | 22 |
2022 | 22 | 3 | 25 |
2023 | 12 | 0 | 12 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
-
Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2024 Mar 01; 73(3):385-390.
-
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 Mar; 72(3):294-304.
-
Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy. J Clin Endocrinol Metab. 2023 Dec 21; 109(1):e209-e215.
-
GSK-3? as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance. Intervirology. 2024; 67(1):6-18.
-
A Maternal Western-Style Diet Impairs Skeletal Muscle Lipid Metabolism in Adolescent Japanese Macaques. Diabetes. 2023 Dec 01; 72(12):1766-1780.
-
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes. Front Endocrinol (Lausanne). 2023; 14:1286838.
-
Fetal sex and the development of gestational diabetes mellitus in gravidae with multiple gestation pregnancies. Acta Obstet Gynecol Scand. 2023 12; 102(12):1703-1710.
-
Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice. Diabetologia. 2023 12; 66(12):2368-2386.
-
Associations between avocado intake and measures of glucose and insulin homeostasis in Hispanic individuals with and without type 2 diabetes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Nutr Metab Cardiovasc Dis. 2023 Dec; 33(12):2428-2439.